Active: Alzheimer's disease biomarkers Clear all

GWAS 2013-04-04

GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer's disease.

Cruchaga C, Kauwe JS et al.

Neuron

Cerebrospinal fluid (CSF) tau, tau phosphorylated at threonine 181 (ptau), and Aβ₄₂ are established ...

Alzheimer's disease biomarkers

1278

Participants

N/A

Studies

Details PubMed

GWAS 2013-02-19

APOE and BCHE as modulators of cerebral amyloid deposition: a florbetapir PET genome-wide association study.

Ramanan VK, Risacher SL et al.

Mol Psychiatry

Deposition of amyloid-β (Aβ) in the cerebral cortex is thought to be a pivotal event in Alzheimer's ...

Alzheimer's disease biomarkers

555

Participants

N/A

Studies

Details PubMed

GWAS 2010-12-01

Genome-wide association study of CSF biomarkers Abeta1-42, t-tau, and p-tau181p in the ADNI cohort.

Kim S, Swaminathan S et al.

Neurology

Objectives: CSF levels of Aβ1-42, t-tau, and p-tau181p are potential early diagnostic markers for pr...

Alzheimer's disease biomarkers

374

Participants

N/A

Studies

Details PubMed

Title

Author

Journal

Disease/Trait

Date

Actions

GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer's disease.

Cruchaga C, Kauwe JS et al.

Neuron

Alzheimer's disease biomarkers

2013-04-04

APOE and BCHE as modulators of cerebral amyloid deposition: a florbetapir PET genome-wide association study.

Ramanan VK, Risacher SL et al.

Mol Psychiatry

Alzheimer's disease biomarkers

2013-02-19

Genome-wide association study of CSF biomarkers Abeta1-42, t-tau, and p-tau181p in the ADNI cohort.

Kim S, Swaminathan S et al.

Neurology

Alzheimer's disease biomarkers

2010-12-01